FDA Panel Backs Novel Anti-HER2 Drug for Breast Cancer
(MedPage Today) -- Dissenters cite toxicity, modest benefit
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | International Medicine & Public Health | Toxicology